Cargando…

DNMT3A(R882)-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3A(R882C) OCI-AML3 leukemia cell line

Detalles Bibliográficos
Autores principales:	Chen, David, Christopher, Matthew, Helton, Nichole M., Ferguson, Ian, Ley, Timothy J., Spencer, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884841/ https://www.ncbi.nlm.nih.gov/pubmed/29618788 http://dx.doi.org/10.1038/s41408-018-0072-9

Ejemplares similares

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2019)

The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes
por: Emperle, Max, et al.
Publicado: (2018)

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
por: Yang, Li, et al.
Publicado: (2019)

DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
por: Jawad, Majd, et al.
Publicado: (2022)

DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

Gene expression profiling of the DNMT3A R882 mutation in acute leukemia
por: HUANG, XIANGNAN, et al.
Publicado: (2013)

Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
por: Berenstein, Rimma, et al.
Publicado: (2015)

The DNMT3A R882H mutant displays altered flanking sequence preferences
por: Emperle, Max, et al.
Publicado: (2018)

Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation
por: Anteneh, Hiwot, et al.
Publicado: (2020)

The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme
por: Norvil, Allison B, et al.
Publicado: (2020)

Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Lin, Jiang, et al.
Publicado: (2011)

Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis
por: Liao, Min, et al.
Publicado: (2021)

DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation
por: Koya, Junji, et al.
Publicado: (2016)

Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
por: Emperle, Max, et al.
Publicado: (2019)

Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells
por: Bera, Rabindranath, et al.
Publicado: (2018)

Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs
por: Yang, Li, et al.
Publicado: (2017)

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway
por: Chu, Xuan, et al.
Publicado: (2022)

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
por: Scourzic, Laurianne, et al.
Publicado: (2016)

Understanding the R882H mutation effects of DNA methyltransferase DNMT3A: a combination of molecular dynamics simulations and QM/MM calculations
por: Liu, Lanxuan, et al.
Publicado: (2019)

Rapid Detection of DNMT3A R882 Mutations in Hematologic Malignancies Using a Novel Bead-Based Suspension Assay with BNA(NC) Probes
por: Shivarov, Velizar, et al.
Publicado: (2014)

Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype
por: Chen, David Y., et al.
Publicado: (2021)

FLT3-ITD与DNMT3A R882双突变对急性髓系白血病异基因造血干细胞移植预后的影响
Publicado: (2018)

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

882 Risk Factors for Ventilator Associated Events
por: Nuckchady, Dooshanveer, et al.
Publicado: (2014)

Edition Eulenburg No. 882 Suite for Treble Recorder and String Orchestra. A minos

Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line
por: Cela, Ilaria, et al.
Publicado: (2022)

FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
por: Ardestani, Majid Teremmahi, et al.
Publicado: (2018)

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations
por: Sidorova, Olga Alexandra, et al.
Publicado: (2022)

Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells
por: Wang, Qiwei, et al.
Publicado: (2022)

Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants
por: Van Emburgh, Beth O., et al.
Publicado: (2011)

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
por: Dunlap, Jennifer B., et al.
Publicado: (2019)

Comparison of High-Resolution Melting (HRM) Analysis with Direct Sequencing for the Detection of DNMT3A Mutations in AML Patients
por: Moonesi, Mohammadreza, et al.
Publicado: (2022)

P456: LEUKEMOGENESIS BY AML-SPECIFIC DRIVER MUTATIONS WITHIN DNMT3A, IDH2 AND NPM1
por: Mehmetbeyoglu, Ecmel, et al.
Publicado: (2023)

CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations
por: Tang, Ling, et al.
Publicado: (2022)

Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML
por: Wang, JingHan, et al.
Publicado: (2020)

miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1
por: Chen, Zhiheng, et al.
Publicado: (2015)

Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells
por: Liao, Jing, et al.
Publicado: (2015)

Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia
por: Wong, Kah Keng, et al.
Publicado: (2019)

The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
por: Heiblig, Maël, et al.
Publicado: (2021)

CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML
por: Liu, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ta2h5l8ari315189175uon0v9v